Airfinity Launches an RNA Therapeutics and Vaccine Intelligence Tool

Posted on May 16, 2023

Airifinity has launched an RNA Treatments and Vaccines Platform providing insights and a holistic overview of the whole RNA landscape monitoring candidates and delivery system technology from preclinical to clinical and through to commercialisation. The platform tracks candidates, clinical trials, delivery systems, RNA manufacturing sites and capacities, a delivery system demand model, new approvals, new deals, media and press releases, as well as company interactions such as licensing agreements, partnerships, and M&A.

What is Airfinity’s RNA intelligence platform?

→ An overview of 700+ candidates in development and changes to the candidate clinical and preclinical landscape.

→ RNA Manufacturing Map including HQ, R&D, CDMO, CRO, and CMO sites

→ Material type over time for GMP grade RNA candidates to predict future demand.

→ Clinical trial overviews including new locations and announced timelines of completion.

→ New approvals and expedited status designations.

→ New funding deals.

→ A network interaction map of how companies within the RNA space interact (licensing agreements, partnerships, collaborations, mergers and acquisitions).

→ Media and press releases.

→ RNA facilities map including HQ, R&D, CDMO, CRO, and CMO sites.

→ An overview of generic and proprietary delivery system technologies in development.

To request a free demo of the platform and speak with our specialist team, get in touch here.

More Insights From Airfinity

Introducing Airfinity Biorisk: Risk Surveillance and Analytics for 160+ Infectious Diseases

Oct 10, 2022

18 million monkeypox vaccines needed to protect most at risk, 85 million to protect wider gay community and health workers

Aug 25, 2022

Sales of COVID-19 antiviral pill Paxlovid to leap frog Merck’s competitor Molnupiravir

Jul 25, 2022

COVID-19 vaccines sales to bounce back with new jabs taking a fifth of the 2022 market

Jul 15, 2022

AstraZeneca and Pfizer/BioNTech saved over 12 million lives in the first year of vaccination

Jul 13, 2022

Global wastage of COVID-19 vaccines could be 1.1 billion doses

Jul 11, 2022